Skip to main content
Normal View

Medical Products

Dáil Éireann Debate, Tuesday - 19 May 2015

Tuesday, 19 May 2015

Questions (280, 283, 285)

Michael Healy-Rae

Question:

280. Deputy Michael Healy-Rae asked the Minister for Health the exact pattern of adverse effects for Roaccutane; and if he will make a statement on the matter. [19167/15]

View answer

Michael Healy-Rae

Question:

283. Deputy Michael Healy-Rae asked the Minister for Health in view of the fact that the Health Products Regulatory Authority has 289 adverse drug reaction reports, in association with Roaccutane since 1983, if he will identify these individually, by gender, year, and age; if he will provide a chronological list of these reports; and if he will make a statement on the matter. [19177/15]

View answer

Michael Healy-Rae

Question:

285. Deputy Michael Healy-Rae asked the Minister for Health the number of adverse drug reports that a pharmaceutical company (details supplied) submitted to the Health Products Regulatory Authority, in association with Roaccutane, since 1983; and if he will make a statement on the matter. [19179/15]

View answer

Written answers

I propose to take Questions Nos. 280, 283 and 285 together.

The information requested is not readily available and will be forwarded directly to the Deputy by the Health Products Regulatory Authority (HPRA).

Top
Share